KDOQI (Kidney Disease Outcomes Quality Initiative)
NKF KDOQI GUIDELINES

Executive Summaries | Anemia | Hemodialysis | Peritoneal Dialysis |
Vascular Access | Nutrition | CKD 2002 | Dyslipidemias | Bone Metabolism | Hypertension and Antihypertensive Agents | Cardiovascular Disease in Dialysis Patients | History of KDOQI | Pediatric Bone | Anemia 2006 |
Updates 2006

Clinical Practice Guidelines and Clinical Practice Recommendations
2006 Updates
Hemodialysis Adequacy
Peritoneal Dialysis Adequacy
Vascular Access


II. CLINICAL PRACTICE RECOMMENDATIONS FOR VASCULAR ACCESS

CLINICAL PRACTICE RECOMMENDATIONS FOR GUIDELINE 4: DETECTION OF ACCESS DYSFUNCTION: MONITORING, SURVEILLANCE, AND DIAGNOSTIC TESTING

4.1 Monitoring the access:

4.2 Frequency of measurement is dependent on the method used:

4.3 Frequency of measurement for access complications:

4.4 Diagnostic testing:

RATIONALE
There is considerable debate concerning whether PTA interventions improve long-term outcomes. Until sufficiently powered clinical studies are performed, the rationale for monitoring and surveillance are provided in CPG 4. It is the belief of the Work Group that physical examination and clinical evaluation are forgotten skills that, if restored, could be as valuable as any surveillance method.

The utility of any method develops on sequential assessment and evaluation. This requires collection and storage of observations and/or data. Because stenoses evolve over time, observations and data should change over time. Because observers may change, data must be available to all caretakers.

Quality and outcome improvement cannot be determined without analyses of data.